CME Group (NASDAQ:CME) Stock Price Expected to Rise, Piper Sandler Analyst Says

CME Group (NASDAQ:CME - Get Free Report) had its price target upped by Piper Sandler from $283.00 to $296.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an "overweight" rating on the financial services provider's stock. Piper Sandler's price target suggests a potential upside of 7.75% from the stock's current price.

Other equities analysts have also issued reports about the company. Citigroup boosted their price target on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Barclays boosted their price target on CME Group from $283.00 to $299.00 and gave the company an "equal weight" rating in a research note on Thursday, July 10th. Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. JPMorgan Chase & Co. cut their price target on CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a report on Thursday, April 24th. Finally, Oppenheimer increased their price target on CME Group from $282.00 to $300.00 and gave the stock an "outperform" rating in a report on Wednesday, June 4th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $261.80.

CME Group Trading Down 1.1%

Shares of NASDAQ CME traded down $3.12 during trading on Tuesday, reaching $274.70. The company had a trading volume of 2,197,249 shares, compared to its average volume of 2,178,669. The company's fifty day moving average price is $276.08 and its 200-day moving average price is $260.36. CME Group has a 12 month low of $193.25 and a 12 month high of $290.79. The stock has a market cap of $98.99 billion, a P/E ratio of 27.64, a PEG ratio of 4.86 and a beta of 0.44. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the company posted $2.50 EPS. The business's revenue was up 10.4% on a year-over-year basis. As a group, research analysts expect that CME Group will post 10.49 earnings per share for the current year.

Insider Transactions at CME Group

In other CME Group news, Director William R. Shepard purchased 256 shares of the firm's stock in a transaction that occurred on Wednesday, June 25th. The stock was bought at an average cost of $270.53 per share, with a total value of $69,255.68. Following the completion of the transaction, the director owned 258,196 shares of the company's stock, valued at $69,849,763.88. The trade was a 0.10% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, General Counsel Jonathan L. Marcus sold 390 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $277.50, for a total value of $108,225.00. Following the sale, the general counsel directly owned 6,708 shares of the company's stock, valued at $1,861,470. The trade was a 5.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,400 shares of company stock valued at $3,680,610. Corporate insiders own 0.30% of the company's stock.

Hedge Funds Weigh In On CME Group

Several institutional investors and hedge funds have recently bought and sold shares of CME. Norges Bank bought a new position in shares of CME Group in the fourth quarter worth $1,107,389,000. Price T Rowe Associates Inc. MD boosted its holdings in shares of CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after acquiring an additional 3,921,278 shares during the period. GQG Partners LLC boosted its holdings in shares of CME Group by 7,676.3% in the first quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider's stock worth $584,975,000 after acquiring an additional 2,176,685 shares during the period. Wellington Management Group LLP boosted its holdings in shares of CME Group by 370.5% in the first quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock worth $704,068,000 after acquiring an additional 2,089,935 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of CME Group by 32,941.0% in the first quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock worth $493,144,000 after acquiring an additional 1,853,261 shares during the period. 87.75% of the stock is owned by institutional investors.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.